Drug Shortage Report for APO-CANDESARTAN/HCTZ
Report ID | 21199 |
Drug Identification Number | 02367866 |
Brand name | APO-CANDESARTAN/HCTZ |
Common or Proper name | CANDESARTAN + HCTZ |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL |
Strength(s) | 12.5MG 16.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BTL & 30 BLS |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-09-04 |
Estimated end date | |
Actual end date | 2018-02-23 |
Shortage status | Resolved |
Updated date | 2018-02-26 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2018-02-26 | French | Compare |
v16 | 2018-02-26 | English | Compare |
v15 | 2018-02-26 | English | Compare |
v14 | 2018-02-21 | French | Compare |
v13 | 2018-02-21 | English | Compare |
v12 | 2018-02-05 | French | Compare |
v11 | 2018-02-05 | English | Compare |
v10 | 2018-02-01 | French | Compare |
v9 | 2018-02-01 | English | Compare |
v8 | 2018-01-31 | French | Compare |
v7 | 2018-01-31 | English | Compare |
v6 | 2017-11-07 | French | Compare |
v5 | 2017-11-07 | English | Compare |
v4 | 2017-09-22 | French | Compare |
v3 | 2017-09-22 | English | Compare |
v2 | 2017-09-07 | French | Compare |
v1 | 2017-09-07 | English | Compare |
Showing 1 to 17 of 17